Back to Screener

Healthcare

Zenas BioPharma, Inc.(ZBIO)

Live Price

Offline

$18.58

+2.14% today

1Y Change

+96.20%

Window

Jun 23, 2025 โ†’ Jun 17, 2026

Market Cap
$960.00M
Revenue Growth
+100.0%
EPS Growth
-124.5%
Dividend Yield
0.0%

Coverage: 248 bars ยท Jun 23, 2025 โ†’ Jun 17, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Zenas BioPharma, Inc. (ZBIO) is a Healthcare stock with a market cap of $960.00M and listed on NASDAQ. The stock last traded around $18.58 and up 96.2% across the available one-year price window (Jun 23, 2025 โ†’ Jun 17, 2026). Baseline metrics include revenue growth of +100.0%, EPS growth of -124.5%, a dividend yield of 0.0%. What stands out right now is revenue +100.0%, EPS -124.5%, free cash flow -43.9% with operating margin -2163.8% and ROIC -67.2%. Valuation already assumes a fairly strong business story at price/sales 96.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines ZBIO price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

ZBIO

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

ZBIO Max Drawdown

-64.79%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for ZBIO and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedMay 14, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
โ€”
May 14, 26
โ€”
Est -1.35
โ€”
โ€”
Est 25000.0B
โ€”
May 14
โ€”
Mar 16, 26
โœ—
-4.54
Est -1.22
-272.1%
โ€”
Est 13333.3B
โ€”
Mar 16
โ€”
Nov 12, 25
โœ—
-1.22
Est -0.87
-40.2%
โ€”
Est 28750.0B
โ€”
Nov 12
โ€”
Aug 12, 25
โœ—
-1.25
Est -1.02
-22.6%
โ€”
Est 3750.0B
โ€”
Aug 12
โ€”
May 15, 25
โœ“
-0.80
Est -1.11
+27.9%
10000.0B
Est 1250.0B
+700.0%
May 15
โ€”
Mar 25, 25
โœ—
-3.99
Est -0.92
-333.7%
5000.0B
Est โ€”
โ€”
Mar 25
โ€”
Nov 12, 24
โœ“
-5.02
Est -9.33
+46.2%
โ€”
Est โ€”
โ€”
Nov 12
โ€”
Jun 30, 24
-0.99
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 24
-0.73
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 23
-0.64
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
โ€”
Sep 30, 23
0.85
Est โ€”
โ€”
50000.0B
Est โ€”
โ€”
Sep 30
โ€”
Jun 30, 23
-0.76
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jun 30
โ€”
Mar 31, 23
-0.50
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Mar 31
โ€”
Dec 31, 22
-0.50
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Dec 31
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.

Read the earnings calendar guideOpen the calendar screener